Ligand validation:8PB3

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 8PB3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8PB3_SAH_A_401	86%	46%	0.096	0.963	0.93	1.14	2	2	1	0	100%	1
8PB3_SAH_B_401	82%	50%	0.11	0.966	0.8	1.12	1	2	0	0	100%	1
8PB4_SAH_A_401	91%	48%	0.1	0.987	0.81	1.18	1	2	0	0	100%	1
8PB6_SAH_A_401	90%	42%	0.103	0.988	1.02	1.24	-	4	0	0	100%	1
8QXQ_SAH_A_401	87%	51%	0.109	0.982	0.84	1.04	1	2	0	0	100%	1
8PB8_SAH_B_401	79%	54%	0.127	0.974	0.79	0.97	1	1	0	0	100%	1
5PA0_SAH_A_301	100%	32%	0.043	0.994	1.11	1.59	2	3	1	0	100%	1
5P9P_SAH_A_304	100%	46%	0.043	0.992	0.96	1.12	-	2	1	0	100%	1
7UX7_SAH_A_401	100%	61%	0.046	0.994	0.66	0.84	-	1	0	0	100%	1
4QPN_SAH_A_301	100%	49%	0.046	0.993	0.91	1.05	2	-	0	0	100%	1
5P9O_SAH_A_302	100%	30%	0.044	0.991	1.38	1.42	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.